1. Home
  2. KURA vs ORRF Comparison

KURA vs ORRF Comparison

Compare KURA & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • ORRF
  • Stock Information
  • Founded
  • KURA 2014
  • ORRF 1919
  • Country
  • KURA United States
  • ORRF United States
  • Employees
  • KURA N/A
  • ORRF N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ORRF Major Banks
  • Sector
  • KURA Health Care
  • ORRF Finance
  • Exchange
  • KURA Nasdaq
  • ORRF Nasdaq
  • Market Cap
  • KURA 492.9M
  • ORRF 588.6M
  • IPO Year
  • KURA N/A
  • ORRF N/A
  • Fundamental
  • Price
  • KURA $5.61
  • ORRF $30.13
  • Analyst Decision
  • KURA Strong Buy
  • ORRF Buy
  • Analyst Count
  • KURA 12
  • ORRF 3
  • Target Price
  • KURA $24.50
  • ORRF $34.50
  • AVG Volume (30 Days)
  • KURA 1.2M
  • ORRF 110.6K
  • Earning Date
  • KURA 05-01-2025
  • ORRF 07-22-2025
  • Dividend Yield
  • KURA N/A
  • ORRF 3.50%
  • EPS Growth
  • KURA N/A
  • ORRF N/A
  • EPS
  • KURA N/A
  • ORRF 1.84
  • Revenue
  • KURA $67,991,000.00
  • ORRF $203,869,000.00
  • Revenue This Year
  • KURA $171.90
  • ORRF $22.45
  • Revenue Next Year
  • KURA $60.51
  • ORRF $3.45
  • P/E Ratio
  • KURA N/A
  • ORRF $16.07
  • Revenue Growth
  • KURA N/A
  • ORRF 56.29
  • 52 Week Low
  • KURA $5.41
  • ORRF $24.91
  • 52 Week High
  • KURA $23.48
  • ORRF $41.99
  • Technical
  • Relative Strength Index (RSI)
  • KURA 42.00
  • ORRF 47.18
  • Support Level
  • KURA $5.60
  • ORRF $29.31
  • Resistance Level
  • KURA $6.51
  • ORRF $31.45
  • Average True Range (ATR)
  • KURA 0.37
  • ORRF 0.60
  • MACD
  • KURA -0.00
  • ORRF -0.15
  • Stochastic Oscillator
  • KURA 22.33
  • ORRF 16.86

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: